Filing Details
- Accession Number:
- 0001384101-24-000181
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-04 16:59:39
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-04 16:59:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1991536 | John Leite | 6000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Chief Commercial Officer-Clia | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-12-02 | 1,314 | $44.12 | 74,860 | No | 4 | F | Direct | |
Common Stock | Disposition | 2024-12-03 | 1,050 | $43.25 | 73,810 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- The reporting person is reporting the withholding of 814 and 500 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,606 and 986 Restricted Stock Units, respectively, granted on September 1, 2022 and March 6, 2023 respectively, and does not represent a sale by the reporting person.
- The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 1, 2024.
- Represents weighted average sales price. Sale prices for the transactions range from $42.78 to $43.65. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.